Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Aug 19, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immunome Inc.
| 7K |
$13.94 | $97,608.00 | +72.80% | 16.61K |
Aug 16
| |||||||
Immunome Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 13
| |||||||
Incyte Corp
| 2.83K |
—
|
—
| +18.27% | 18.32K |
Jun 12
| |||||||
Keros Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 3
| |||||||
Keros Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Immunome Inc.
| 2K |
$13.57 | $27,139.80 | +26.26% | 9.62K |
May 21
| |||||||
Biomarin Pharmaceutical Inc
| -1.20K |
$77.05 | -$92,614.10 | -0.25% | 473.79K |
May 20
| |||||||
Biomarin Pharmaceutical Inc
|
0
|
$72.24 | -$731,200.00 |
—
| 474.99K |
May 9 - May 10
|
Scheduled
| ||||||
Biomarin Pharmaceutical Inc
|
0
|
$77.11 | -$1,121,000.00 |
—
| 474.99K |
Apr 11 - Apr 12
|
Scheduled
| ||||||
Biomarin Pharmaceutical Inc
| -85.21K |
$83.87 | -$7,146,478.83 | -15.21% | 474.99K |
Mar 15
| |||||||
Biomarin Pharmaceutical Inc
| -2.00K |
$86.11 | -$172,223.00 | -0.36% | 560.2K |
Mar 5 - Mar 6
| |||||||
Biomarin Pharmaceutical Inc
| 142.6K |
$90.35 | -$90,350.00 | +33.98% | 562.2K |
Feb 27
| |||||||
Biomarin Pharmaceutical Inc
| 40 |
$76.09 | -$774,046.10 | +0.01% | 419.6K |
Jan 18 - Feb 9
|
Scheduled
| ||||||
Biomarin Pharmaceutical Inc
| -5.60K |
—
|
—
| -1.32% | 419.56K |
Feb 6 - Feb 9
| |||||||
Biomarin Pharmaceutical Inc
| 50 |
$80.24 | -$678,747.41 | +0.01% | 425.16K |
Jan 8 - Jan 10
|
Scheduled
| ||||||
Biomarin Pharmaceutical Inc
|
0
|
$78.55 | -$308,900.00 |
—
| 425.11K |
Dec 21
|
Scheduled
| ||||||
Biomarin Pharmaceutical Inc
| 2.38K |
$85.57 | $855.66 | +0.56% | 425.11K |
Oct 4 - Dec 1
| |||||||
Immunome Inc.
|
0
|
—
|
—
|
—
|
0
|
Nov 7
| |||||||
Immunome Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Biomarin Pharmaceutical Inc
| -10.00K |
$88.21 | -$882,140.00 | -2.31% | 422.73K |
Aug 7 - Aug 8
| |||||||
Incyte Corp
| 2.5K |
—
|
—
| +19.29% | 15.49K |
Jun 14
| |||||||
Biomarin Pharmaceutical Inc
| 6.52K |
$80.87 | -$602,250.33 | +1.53% | 432.73K |
May 12
| |||||||
Biomarin Pharmaceutical Inc
|
0
|
$81.24 | -$805,925.87 |
—
| 426.21K |
May 11
| |||||||
Biomarin Pharmaceutical Inc
| 317 |
$81.35 | -$1,603,569.55 | +0.07% | 426.21K |
Apr 28 - May 10
| |||||||
Biomarin Pharmaceutical Inc
|
0
|
$83.69 | -$317,500.00 |
—
| 425.9K |
Apr 10
| |||||||
Biomarin Pharmaceutical Inc
|
0
|
$81.97 | -$283,200.00 |
—
| 425.9K |
Apr 6
| |||||||
Biomarin Pharmaceutical Inc
| -61.96K |
$92.86 | -$9,106,276.81 | -12.70% | 425.9K |
Mar 15 - Mar 16
| |||||||
Biomarin Pharmaceutical Inc
|
0
|
$79.72 | -$548,170.00 |
—
| 487.86K |
Mar 10 - Mar 13
|
Scheduled
| ||||||
Biomarin Pharmaceutical Inc
| 167.53K |
—
|
—
| +52.30% | 487.86K |
Feb 28
| |||||||
Biomarin Pharmaceutical Inc
|
0
|
$88.83 | -$882,540.00 |
—
| 567.86K |
Feb 7 - Feb 13
|
Scheduled
| ||||||
Biomarin Pharmaceutical Inc
|
0
|
$89.86 | -$881,800.00 |
—
| 320.42K |
Jan 13 - Jan 17
|
Scheduled
| ||||||
Biomarin Pharmaceutical Inc
| -1.00K |
$106.89 | -$106,890.00 | -0.31% | 320.42K |
Dec 13
| |||||||
Biomarin Pharmaceutical Inc
| -1.40K |
$95.05 | -$147,355.28 | -0.43% | 321.42K |
Nov 2 - Dec 2
| |||||||
Biomarin Pharmaceutical Inc
| -1.50K |
$86.55 | -$129,825.00 | -0.46% | 322.82K |
Oct 31
| |||||||
Biomarin Pharmaceutical Inc
| -4.00K |
$89.89 | -$359,560.00 | -1.22% | 324.32K |
Oct 14
|
Scheduled
| ||||||
Biomarin Pharmaceutical Inc
| -7.00K |
$94.95 | -$664,630.00 | -2.09% | 328.32K |
Aug 12 - Aug 15
|
Scheduled
| ||||||
Incyte Corp
| 2.14K |
—
|
—
| +19.77% | 12.99K |
Jun 15
| |||||||
Biomarin Pharmaceutical Inc
| 341 |
$59.90 | -$1,316,319.21 | +0.10% | 335.32K |
Apr 29 - May 6
|
Scheduled
| ||||||
Biomarin Pharmaceutical Inc
|
0
|
$60.44 | -$1,149,050.00 |
—
| 334.98K |
Apr 28 - Apr 29
|
Scheduled
| ||||||
Biomarin Pharmaceutical Inc
|
0
|
$59.69 | -$889,000.00 |
—
| 334.98K |
Apr 18
|
Scheduled
| ||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.